Unichem Laboratories Limited (BOM:506690)
India · Delayed Price · Currency is INR 543.45
+4.20 (0.78%)
At close: Jul 27, 2026
Unichem Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 22,019 | 22,019 | 21,110 | 17,851 | 13,430 | 12,698 |
Revenue Growth | 4.30% | 4.30% | 18.25% | 32.92% | 5.76% | 2.81% |
Gross Profit Gross Profit Growth | 11,083 | 11,083 | 11,891 | 9,903 | 7,366 | 8,013 |
Operating Income Operating Income Growth | 635.7 | 635.7 | 1,403 | -362.8 | -1,556 | -109.01 |
Net Income Net Income Growth | 2,528 | 2,528 | 1,375 | -937.6 | -2,022 | 330.62 |
Earnings Per Share EPS Growth | 35.85 | 35.85 | 19.47 | -13.32 | -28.72 | 4.68 |
EPS Growth | 84.13% | 84.13% | - | - | - | -4.01% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 331.1 | 331.1 | 407.4 | 409.8 | 322.11 | 412.52 |
USA USA Growth | 14,685 | 14,685 | 13,254 | 10,859 | 7,856 | 7,343 |
Others Others Growth | 6,578 | 6,578 | 6,983 | 6,107 | 4,846 | 4,724 |
Total Total Growth | 21,594 | 21,594 | 20,645 | 17,376 | 13,024 | 12,480 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,895 | 2,895 | 895.8 | 1,561 | 1,853 | 3,728 |
Total Debt Total Debt Growth | 5,002 | 5,002 | 4,598 | 2,475 | 3,140 | 3,492 |
Net Cash (Debt) Net Cash Growth | -2,107 | -2,107 | -3,702 | -914.3 | -1,288 | 236.25 |
Net Cash Growth | - | - | - | - | - | -87.87% |
Net Cash Per Share Net Cash Per Share Growth | -29.87 | -29.87 | -52.42 | -12.99 | -18.29 | 3.35 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 36.4 | 36.4 | -70.2 | 140 | -850.91 | -2,596 |
Capital Expenditures CapEx Growth | -1,230 | -1,230 | -1,374 | -225.5 | -443.16 | -1,270 |
Free Cash Flow Free Cash Flow Growth | -1,194 | -1,194 | -1,444 | -85.5 | -1,294 | -3,866 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 50.34% | 50.34% | 56.33% | 55.47% | 54.85% | 63.10% |
Operating Margin | 2.89% | 2.89% | 6.65% | -2.03% | -11.58% | -0.86% |
Pretax Margin | 13.28% | 13.28% | 7.32% | -4.76% | -13.13% | 1.73% |
Profit Margin | 11.48% | 11.48% | 6.51% | -5.25% | -15.06% | 2.60% |
FCF Margin | -5.42% | -5.42% | -6.84% | -0.48% | -9.63% | -30.45% |
| Fiscal Year | FY 2022 |
|---|---|
| Period Ending | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.000 |
Dividend Per Share Growth | 0% |
Dividend Yield | 1.56% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.16 | 8.18 | 35.47 | - | - | 55.44 |
Forward PE | - | 12.72 | 12.72 | 12.72 | 12.72 | 12.72 |
PS Ratio | 1.74 | 0.94 | 2.31 | 1.93 | 1.52 | 1.44 |